$2.5 million research competition to drive treatments for retinal degeneration
We’re excited to give our eNews readers a sneak peek at a new initiative Fighting Blindness Canada (FBC) is launching this month. This competition will solicit applications from the best and brightest…
Advances in AMD Research: Highlights from View Point
This February we recognized Age-Related Macular Degeneration (AMD) Awareness Month with a special View Point. Our expert panel discussed geographic atrophy (GA), new research on a potential antibody treatment, biosimilars and more….
Optogenetic Therapy To Treat Vision Loss
Optogenetic therapy uses gene editing to add light-sensing molecules to cells. These cells can then be turned on and off by light. This technique has been used in research for many years…
BREAKING NEWS … Canadians one step closer to Luxturna Gene Therapy Access
Fighting Blindness Canada is excited to announce that Canadians are one step closer to being able to access voretigene neparvovec (Luxturna), the first gene therapy for an inherited retinal disease. As of…
Developing a stem cell therapy to restore sight
Fighting Blindness Canada is pleased to announce that the team of Dr. David Gamm (University of Wisconsin) and Dr. William Beltran (University of Pennsylvania) have been awarded $725,000 to continue their ground-breaking…
Health Information Line
Getting diagnosed with an eye disease and navigating tests, appointments, and treatments can be confusing and complicated. Fighting Blindness Canada’s (FBC) Health Information Line is here to answer your eye health-related questions….
Join the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
